AbbVie Inc. Quarterly Goodwill in USD from Q4 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
AbbVie Inc. quarterly Goodwill history and growth rate from Q4 2011 to Q2 2024.
  • AbbVie Inc. Goodwill for the quarter ending June 30, 2024 was $33.4B, a 3.61% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $33.4B +$1.16B +3.61% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $33.4B +$1.21B +3.74% Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $32.3B +$137M +0.43% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $32.1B +$365M +1.15% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $32.2B +$196M +0.61% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $32.2B -$78M -0.24% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $32.2B -$223M -0.69% Dec 31, 2022 10-K 2024-02-20
Q3 2022 $31.7B -$570M -1.77% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $32B -$370M -1.14% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $32.3B -$51M -0.16% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $32.4B -$745M -2.25% Dec 31, 2021 10-K 2024-02-20
Q3 2021 $32.3B -$10.5B -24.5% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $32.4B -$10.3B -24.1% Jun 30, 2021 10-Q 2021-08-02
Q1 2021 $32.3B +$16.8B +108% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $33.1B +$17.5B +112% Dec 31, 2020 10-K 2023-02-17
Q3 2020 $42.8B +$27.3B +175% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $42.7B +$27B +173% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $15.6B -$45M -0.29% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $15.6B -$59M -0.38% Dec 31, 2019 10-K 2022-02-18
Q3 2019 $15.5B -$181M -1.15% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $15.6B -$50M -0.32% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $15.6B -$274M -1.73% Mar 31, 2019 10-Q 2019-05-03
Q4 2018 $15.7B -$122M -0.77% Dec 31, 2018 10-K 2021-02-19
Q3 2018 $15.7B -$30M -0.19% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $15.7B +$40M +0.26% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $15.9B +$390M +2.52% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $15.8B +$369M +2.39% Dec 31, 2017 10-K 2020-02-21
Q3 2017 $15.7B +$91M +0.58% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $15.7B +$145M +0.94% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $15.5B +$2.22B +16.7% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 $15.4B +$2.25B +17.1% Dec 31, 2016 10-K 2019-02-27
Q3 2016 $15.7B +$2.41B +18.2% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $15.5B +$2.3B +17.4% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 $13.3B +$7.74B +140% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 $13.2B +$7.31B +125% Dec 31, 2015 10-K 2018-02-16
Q3 2015 $13.2B +$7.24B +121% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $13.2B +$6.97B +112% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $5.53B -$737M -11.8% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $5.86B -$415M -6.61% Dec 31, 2014 10-K 2017-02-17
Q3 2014 $6B -$275M -4.38% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $6.24B +$124M +2.03% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $6.27B +$211M +3.48% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 $6.28B +$147M +2.4% Dec 31, 2013 10-K 2016-02-19
Q3 2013 $6.28B Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $6.12B Jun 30, 2013 10-Q 2013-08-09
Q1 2013 $6.06B Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $6.13B +$30M +0.49% Dec 31, 2012 10-K 2014-02-21
Q4 2011 $6.1B Dec 31, 2011 10-K 2014-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.